CVS Health Corporation

NYSE:CVS

Medical - Healthcare Plans

Healthcare
$81.35 -0.59%

-$0.59 today

Market cap
$104.08B
Beta
0.62
P/E (TTM)
42.8
EPS (TTM)
$2.30
Dividend yield
2.70%
52W Low $58.50High $102.77

Volume 17.19M

Average 8.19M

CVS Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

CVS Health CorporationNYSE: CVS

Net Receivables · Q2 FY2026 · quarter ended Jun 2026

Net receivables broadly unchanged from a year ago

Net receivables stood at $40.31B at the end of Q2 FY2026, down 0.8% from a year earlier and down 1.7% from the prior quarter. Over 3 fiscal years it compounded at +13.4% a year.

Context

  • Net receivables amounted to 15.9% of total assets at the end of Q2 FY2026, up 0.1 pp from a year earlier.
  • Net receivables increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps falling in the next quarterly balance sheet after a -0.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$40.31B-1.7% QoQ
Last fiscal yearDec 2025
$39.78B+9.1% YoY
Year agoJun 2025
$40.65B-0.8% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.8%——
1 year+9.1%——
3-year CAGR+13.4%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
39.78B USD
Year-over-year change
+9.1%
4-year CAGR
+13.0%

Net Receivables vs competitors

How CVS compares with its peers on the latest reported figures

  • CVS's Jun 2026 net receivables of $40.31B is the highest of the 9 companies compared; the peer median is $10.72B.
  • Its year-over-year change of -0.8% is the 5th highest of 9, against a peer median of -2.6%.
  • Net receivables amounts to 15.9% of total assets for CVS, versus a peer median of 19.6%.
CVS Competitors Peer median
Net Receivables for CVS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CVSCVS Health CorporationJun 2026$40.31B -0.8%+13.4%15.9%
CICigna CorporationSep 2026$31.49B -0.7%+19.2%20.0%
ELVElevance Health Inc.Sep 2026$24.57B +67.7%+9.1%19.2%
UNHUnitedHealth Group IncorporatedSep 2026$20.54B -62.9%+20.1%6.6%
CNCCentene CorporationJun 2026$18.08B -16.1%+10.9%21.8%
MOHMolina Healthcare, Inc.Sep 2026$3.36B -4.4%+15.3%21.5%
HUMHumana Inc.Sep 2026$2.87B +6.7%+25.0%5.0%
OSCROscar Health, Inc.Jun 2026$380.06M -49.0%-27.5%3.4%
ALHCAlignment Healthcare, Inc.Mar 2026$277.68M +29.7%+39.7%22.0%
Peer median (excluding CVS) $10.72B-2.6%+17.3%19.6%

Competitors are the stored peer set for CVS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents9.41B12.95B8.2B8.59B8.51B
Short-term Investments3.12B2.78B3.26B2.41B2.15B
Net Receivables24.43B27.28B35.23B36.47B39.78B
Inventory17.76B19.09B18.03B18.11B19.25B
Other Current Assets5.29B3.54B3.15B3.08B5.03B
Total Current Assets60.01B65.63B67.86B68.65B74.71B
Property, Plant & Equipment (Net)32.02B30.75B30.44B28.94B28.06B
Goodwill79.12B78.15B91.27B91.27B85.48B
Intangible Assets29.03B24.8B29.23B27.32B25.51B
Long-term Investments23.03B21.1B23.02B28.93B32.87B
Tax Assets00007.53B
Other Non-current Assets9.8B7.85B7.91B8.1B6.91B
Total Non-current Assets172.99B162.64B181.87B184.57B186.35B
Total Assets233B228.28B249.73B253.22B261.06B
Account Payables12.54B14.84B14.9B15.89B59.38B
Short-term Debt4.21B1.78B2.97B5.74B5.81B
Tax Payables00000
Deferred Revenue000062M
Other Current Liabilities5.6B2.82B2.47B1.18B23.42B
Total Current Liabilities67.81B69.42B79.19B84.61B88.69B
Long-term Debt51.97B50.48B58.64B60.53B72.88B
Deferred Tax Liabilities6.27B4.02B4.31B3.81B11.36B
Deferred Revenue (Non-current)00000
Other Non-current Liabilities13.39B15.79B14.92B13.64B(2.16B)
Total Non-current Liabilities89.81B87.09B93.9B92.88B96.99B
Total Liabilities157.62B156.51B173.09B177.49B185.68B
Common Stock47.38B48.19B48.99B18M18M
Retained Earnings54.91B56.4B61.6B62.84B61.2B
Accumulated OCI965M(1.26B)(297M)(120M)406M
Other Stockholders Equity00000
Minority Interest306M300M175M170M168M
Total Equity75.38B71.77B76.64B75.73B75.38B
Total Debt76B70.73B79.39B82.92B93.59B
Net Debt66.59B57.79B71.19B74.33B85.08B

CVS Health Corporation

NYSE:CVS

Intrinsic Alpha fair value

Locked

Current Price

$81.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.